申请人:Pfizer Inc.
公开号:US06174895B1
公开(公告)日:2001-01-16
A compound of the formula
or the pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are as defined above, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and central nervous system disorders such as asthma, chronic obstructive pulmonary disease, adult respiratory diseases syndrome, toxic shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis, cachexia, Crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
该化合物的公式或其药物可接受的盐,其中R1,R2和R3的定义如上所述,可用于治疗呼吸系统、过敏性、风湿性、体重调节、炎症和中枢神经系统疾病,如哮喘、慢性阻塞性肺病、成人呼吸系统疾病综合征、毒性休克、纤维化、肺过敏、过敏性鼻炎、特应性皮炎、银屑病、体重控制、类风湿性关节炎、消瘦、克罗恩病、溃疡性结肠炎、关节炎和其他炎症性疾病、抑郁症、多发性梗塞性痴呆和艾滋病。